BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11986945)

  • 1. CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death.
    Rappl G; Abken H; Muche JM; Sterry W; Tilgen W; André S; Kaltner H; Ugurel S; Gabius HJ; Reinhold U
    Leukemia; 2002 May; 16(5):840-5. PubMed ID: 11986945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.
    Roberts AA; Amano M; Felten C; Galvan M; Sulur G; Pinter-Brown L; Dobbeling U; Burg G; Said J; Baum LG
    Mod Pathol; 2003 Jun; 16(6):543-51. PubMed ID: 12808059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
    Rappl G; Muche JM; Abken H; Sterry W; Tilgen W; Ugurel S; Reinhold U
    J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
    Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
    J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.
    Hristov AC; Vonderheid EC; Borowitz MJ
    Am J Clin Pathol; 2011 Dec; 136(6):944-53. PubMed ID: 22095381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).
    Vonderheid EC; Bigler RD; Kotecha A; Boselli CM; Lessin SR; Bernengo MG; Polansky M
    J Invest Dermatol; 2001 Sep; 117(3):654-62. PubMed ID: 11564173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
    Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
    Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 is a growth factor for Sézary lymphoma cells.
    Dalloul A; Laroche L; Bagot M; Mossalayi MD; Fourcade C; Thacker DJ; Hogge DE; Merle-Béral H; Debré P; Schmitt C
    J Clin Invest; 1992 Sep; 90(3):1054-60. PubMed ID: 1381718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells.
    Koh HS; Lee C; Lee KS; Park EJ; Seong RH; Hong S; Jeon SH
    Mol Cells; 2009 Dec; 28(6):553-8. PubMed ID: 19937140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome.
    Dummer R; Nestle FO; Niederer E; Ludwig E; Laine E; Grundmann H; Grob P; Burg G
    Arch Dermatol Res; 1999 Jun; 291(6):307-11. PubMed ID: 10421055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15).
    Rappl G; Abken H; Hasselmann DO; Tilgen W; Ugurel S; Reinhold U
    Cell Death Differ; 2001 Apr; 8(4):395-402. PubMed ID: 11550091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas.
    Laetsch B; Häffner AC; Döbbeling U; Seifert B; Ludwig E; Burg G; Dummer R
    J Invest Dermatol; 2000 Jan; 114(1):107-11. PubMed ID: 10620124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic identification of Sezary cells in peripheral blood.
    Bogen SA; Pelley D; Charif M; McCusker M; Koh H; Foss F; Garifallou M; Arkin C; Zucker-Franklin D
    Am J Clin Pathol; 1996 Dec; 106(6):739-48. PubMed ID: 8980349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.
    Introcaso CE; Hess SD; Kamoun M; Ubriani R; Gelfand JM; Rook AH
    J Am Acad Dermatol; 2005 Sep; 53(3):428-34. PubMed ID: 16112348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous IL-8 production by CD4(+), CD7(+) leukemia cells in erythrodermic Sézary syndrome.
    Ogawa F; Shimizu K; Hamasakia Y; Tanaka Y; Katayama I; Yamada Y; Tomonaga M
    Leuk Lymphoma; 2002 May; 43(5):1061-6. PubMed ID: 12148887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death.
    Pace KE; Hahn HP; Pang M; Nguyen JT; Baum LG
    J Immunol; 2000 Sep; 165(5):2331-4. PubMed ID: 10946254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD7-positive Sézary syndrome with a Th1 cytokine profile.
    Yagi H; Tokura Y; Furukawa F; Takigawa M
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
    Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
    Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
    Tendler CL; Burton JD; Jaffe J; Danielpour D; Charley M; McCoy JP; Pittelkow MR; Waldmann TA
    Cancer Res; 1994 Aug; 54(16):4430-5. PubMed ID: 7913876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.